Form 4 for ORGO Organogenesis Holdings Inc.
Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-15 · accession 0001062993-25-002940 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-19 | 2025-02-15 | ORGO | Cavorsi Robert | VP, Strategy | F - Tax | $3.70 | -11.0K | 128.8K | -8% | -$40.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-02-15 | F | D | 5,000 | $3.70 | 134,766 | D | — | — | |
| 2 | Common | Class A Common Stock | 2025-02-15 | F | D | 6,008 | $3.70 | 128,758 | D | — | — |